Related Experiment Video
Updated: Jun 8, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery
Edward E Walsh1, Linda Greene, Ronald Kirshner
1Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry and Rochester General Hospital, Rochester, NY 14621, USA. Edward.walsh@rochestergeneral.org
Background:
Methicillin-resistant Staphylococcus aureus (MRSA) wound infections after cardiac surgery have increased in recent years and carry significant morbidity and mortality. In our hospital, MRSA accounted for 56% of postoperative infections.
Methods:
Postoperative wound infection rates were compared for the 3 years before (baseline period) and after (intervention period) introduction of a comprehensive MRSA intervention program. The intervention included preoperative screening for MRSA colonization, administration of intravenous vancomycin prophylaxis for identified carriers, administration of intranasal mupirocin calcium ointment to all patients regardless of colonization status for 5 days beginning the day before surgery, and application of mupirocin to chest tube sites at the time of removal.
Results:
Postoperative MRSA wound infections decreased by 93% (32 infections per 2767 cases in the baseline period vs 2 infections per 2496 cases in the intervention period; relative risk, 0.069; P < .001). Overall wound infection rates decreased from 2.1% to 0.8% (59 infections per 2769 cases vs 20 infections per 2496 cases; P < .001). During the intervention period, there was no change in the number of MRSA infections after noncardiac surgery.
Conclusion:
This MRSA intervention program, in which all patients receive intranasal mupirocin and patients colonized with MRSA receive vancomycin prophylaxis, has resulted in a near-complete and sustained elimination of MRSA wound infections after cardiac surgery.
Insights
A comprehensive intervention program significantly reduced Methicillin-resistant Staphylococcus aureus (MRSA) wound infections after cardiac surgery by 93%. The program involved screening, vancomycin for carriers, and intranasal mupirocin for all patients.
Area of Science:
- Infectious Diseases
- Surgical Site Infections
- Antimicrobial Resistance
Background:
- Rising rates of Methicillin-resistant Staphylococcus aureus (MRSA) wound infections post-cardiac surgery pose significant clinical challenges.
- MRSA accounted for 56% of postoperative infections in the study hospital, highlighting the need for effective control measures.
Purpose of the Study:
- To evaluate the effectiveness of a comprehensive intervention program in reducing MRSA wound infections following cardiac surgery.
- To assess the impact of the intervention on overall postoperative wound infection rates.
Main Methods:
- A comparative study design was employed, comparing infection rates in the 3 years before and after the intervention.
- The intervention included: preoperative MRSA screening, vancomycin prophylaxis for carriers, and universal 5-day intranasal mupirocin application pre-surgery.
- Mupirocin was also applied to chest tube sites upon removal.
Main Results:
- Postoperative MRSA wound infections decreased by 93% (32 to 2 cases), with a relative risk of 0.069 (P < .001).
- Overall wound infection rates dropped from 2.1% to 0.8% (P < .001).
- No significant change in MRSA infections after non-cardiac surgery was observed during the intervention period.
Conclusions:
- A comprehensive MRSA intervention program, combining universal intranasal mupirocin with targeted vancomycin prophylaxis, achieved near-complete elimination of MRSA wound infections post-cardiac surgery.
- The observed reduction in MRSA infections was sustained, demonstrating the program's long-term efficacy.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Endocarditis III: Medical Management